Analyst target price targets were adjusted for multiple companies, including American Express, BioCryst Pharmaceuticals, and American Airlines Group.
2 reports, 1 independent
Updated Jul 9
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst target price targets were adjusted for multiple companies, including American Express, BioCryst Pharmaceuticals, and American Airlines Group.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
American Express
American multinational financial services corporation
-
Cantor Fitzgerald
American financial services company
-
BioCryst Pharmaceuticals
American pharmaceutical company
Nothing else this week.
Related events
- Analyst firms issued price targets and ratings involving Benchmark, Booking Holdings, and Cantor Fitzgerald.
- Analyst action influenced stock price targets for companies including UBS, Alphabet Inc., Cantor Fitzgerald, and JPMorgan Chase.
- An analyst raised Microsoft's price target to $608, noting that MSFT outperformed Nasdaq in 2026.
- Analysts raised price targets and buy ratings for American Express by Goldman Sachs.
- Analyst rating targets influenced the stock price of Hudson Pacific Properties.